Acceleron is a Cambridge, Massachusetts-based biopharmaceutical company dedicated to the discovery and development of innovative, life-changing medicines for patients with serious and rare diseases. Learn more about our clinical pipeline here.
Acceleron Pharma Inc. (NASDAQ: XLRN)
Events & Presentations
Dec 3, 2018
9:00 AM ESTAcceleron ASH 2018 Conference Call
Nov 16, 2018
9:00 AM ESTAcceleron PAH R&D Deep Dive Event
Oct 30, 2018
4:30 PM EDTAcceleron Q3 Earnings Call
Oct 2, 2018
9:30 AM EDTLEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
Copyright West LLC. Minimum 15 minutes delayed.